European Psychiatry - Volume 41 - April 2017

839 / 916

25th European Congress of Psychiatry / European Psychiatry 41S (2017) S772–S846 S835
for the first time too. Drug abuse was detected in that hospital-
ization (cannabis and alcohol). In 2001 was diagnosed of paranoid
schizophrenia. In 2007 the diagnosis was modified to schizoaffec-
tive disorder and also was detected high blood pressure, Diabetes
Mellitus II andoverweight. From2007 to the present he passed from
a scheme treatment composed by four or more psychotropic drugs
tomonotherapy (only one psychotropic drug, an anti-psychotic), he
stayed clinically stable and all his metabolic parameters remained
equal or improved.
Disclosure of interest Janssen-Cilag research study.
EV1312
Enjoying expression: Exploring the
benefits of music therapy on patients
diagnosed with schizophrenia and
using metaphor
games/improvisations for increasing
emotional awareness level
Ö. Salur ∗, E. Ala-Ruona , S. Uc¸ ar , N. Eren
1 University of Jyväskylä, Music Psychology/Music Therapy, Istanbul,
Turkey
2 University of Jyväskylä, Music Psychology/Music Therapy,
Jyväskylä, Finland
3 Istanbul University, Psychiatry Department, Istanbul, Turkey
∗ Corresponding author.
Although music therapy is an evidence-based and effective ther-
apy method in clinical psychiatric settings all around the world,
the literature on music therapy’s effect specifically on emotional
awareness is very limited. This study, which has been conducted as
a part of presenter’s music therapy master’s thesis aims to exam-
ine the clinical benefits of music therapy in a Turkish university
hospital, to enable further research and promote the recognition of
music therapy as a valid clinical method in psychiatry in this coun-
try. A study was conducted in Istanbul university psychiatry clinic
with 6 patients currently under standard care due to diagnoses
of schizophrenia or schizophrenia-like disorders by the hospital
staff. The participants attended 20music therapy sessionswith pre-
post clinical psychological tests applied around the sessions. The
results reveal that group music therapy supports the well being
of outpatients diagnosed with schizophrenia. Significant changes
on general functionality, personal and social performance, depres-
sion levels, increase in the level of ways of coping with stress and
decrease in difficulties in emotion regulation concerning emotional
awareness and are reported. Music therapy games/improvisations
using animals as metaphors were played to reach emotional con-
tent of patients that normally have very limited verbal sharing in
sessions, which possibly effected the change on emotional aware-
ness. Session notes consisting of the therapy crew’s observations
support the statistical analysis of these benefits. These findings
show that music therapy can be beneficial on multiple dimensions,
including emotional awareness, in a Turkish university hospital;
and therefore, more implication opportunities are suggested.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV1313
Pre-morbid personality trait and
cognitive function impact on
schizophrenia course and social
maladaptation
D. Samburskis
Riga Center of Psychiatry and Narcology, Psychiatry, Riga, Latvia
Background Certain personality traits are found in persons with
high risk for schizophrenia onset and therefore it could be used as
diagnostic marker.
Objectives To analyze correlations between personality traits and
cognitive functions on schizophrenia onset and its course and social
adaptation.
Methods This was a retrospective cohort study conducted in Riga
center of psychiatry and narcology, Latvia. Study consisted of two
parts. In the first part, data on first presentation schizophrenia
patients hospitalized in 2006 was collected from medical records.
Patients without completed MMPI, Schulte table; visual memory
and 10 words recall tests were excluded from study group. The
Second part of the study consisted of participant interviews that
were held in early 2016 acquiring demographic data and each par-
ticipant completed a Sheehan disability scale (SDS). Microsoft Excel
2016 and SPSSv22 were used for data operation.
Results Study group consisted of 11 males and 20 females
(35.5%/64.5%). Mean age of participants was 37 years (IQR = 48–33),
butmean age at onset of first schizophrenia symptomswas 27 years
(IQR = 37–21). 68% (n = 21) of participants had schizoid personality
traits as per MMPI and they had higher results on all SDS sub-
scales. There was a negative correlation between the SDS score in
the first section with the occupational level in 2006 (P = 0.065) and
2016 (P= 0.040) and marital status in 2016 (P = 0.040) in those with
psychopathy scale.
Conclusion The hypothesis that schizoid personality traits are a
leading factor in the onset of schizophrenia, have not been proven.
Schizophrenia patients with psychopathic personality traits are
likely to have better social adaptation.
Disclosure of interest The author has not supplied his/her decla-
ration of competing interest.
EV1314
Is there a “critical age” for first use of
marijuana? Analysis of cannabis
induced experiences by age at first use
in a large internet-based sample
M. Sami∗, S. Bhattacharyya
Institute of Psychiatry, Psychology and Neuroscience, Department of
Psychosis Studies, London, United Kingdom
∗ Corresponding author.
Introduction Increased psychotomimetic response to cannabis is
demonstrated in psychosis-prone individuals. Early use of cannabis
has poorer prognostic outcomes. However, as yet no cut-off age for
early use has been established.
Aims and objectives To determine, if age at first use affects later
cannabis experiences and to determine if a “critical age” of first use
exists for psychotomimetic cannabis experiences.
Methods The cannabis experiences questionnaire (CEQ) (EUGEI
version) was administered to a large internet-based non-clinical
sample. Regression analysis was conducted of age at first use
against CEQ scores controlling for gender, age frequency of use
and duration of use. To determine cut-off age: independent ‘t’ tests
(parametric) and Mann–Whitney-U tests (non-parametric) were
used to determine significance of differences in CEQ scores at cut-
off ages from 12-25.
Results We obtained data for 1115 participants. Younger
age at first use was significantly associated with increased
psychotomimetic experiences (adjusted P < 0.001). All cannabis
experiences were increased in in those commencing at younger
age at every cut off age from 17 to 22 (P < 0.001) with maximal dif-
ference at 22. Psychotic experiences significantly varied from age
of first use of 19 to 22 with maximal difference at cut-off ages 20,
21 and 22 ( P< 0.001). Pleasurable experiences were significantly
reduced in those commencing later at every cut-off age from age of